---
title: Ascend vs Cell and Gene Therapy Catapult
slug_a: ascend-adv
slug_b: ct
site: cdmo
review_signal_gate: closed
canonical_path: /compare/ascend-adv/ct
---

# Ascend vs Cell and Gene Therapy Catapult

Side-by-side profile data from each company listing on this directory.

## Ascend

- Profile: [/companies/ascend-adv](/companies/ascend-adv)

Ascend — Ascend is a gene-to-GMP development partner specializing in advanced biologics and vaccines with 60+ years of custom biologics expertise and 20+ years of AAV development capability. The company offers onsite fill-finish capabilities across multiple US locations and combines next-generation technologies with deep regulatory acumen.

Services: 8. Modalities: 3. Indications: 2. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Biologics Development & Manufacturing
- Upstream Processing
- Downstream Processing
- Viral Vector Manufacturing
- AAV Manufacturing
- Vaccine Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development

### Modalities

- Gene Therapy
- Vaccine
- AAV / Viral Vector Platform

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Expression: Viral Vector

## Cell and Gene Therapy Catapult

- Profile: [/companies/ct](/companies/ct)

Cell and Gene Therapy Catapult — UK-based innovation and manufacturing support organization for cell and gene therapies, offering infrastructure, expertise, and collaboration across the ATMP lifecycle.

Services: 13. Modalities: 3. Indications: 4. Locations: 5. Certifications: 0. The strongest documented coverage currently appears in services (13).

### Services

- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Viral Vector
- Single-Use / Disposable